Table 1.

Summary of cases with ECMO of myocarditis from immune checkpoint inhibitors.

Authors, year	Age, sex	Malignancy	ICI	Doses prior to myocarditis	Treatments utilized	Outcome
Arangalage et al. (2017)	35, F	Melanoma	Ipi 3 mg/kg, Nivo 1 mg/kg	1	Intravenous solumedrol 1 g/day and IVIG followed by ECMO and plasma exchange followed by tacrolimus	Survived
Frigeri et al. (2018)	76, F	Metastatic lung adenocarcinoma	Nivo (dose NA)	7	ECMO, IABP, intravenous methylprednisolone 5 mg/kg/day, plasmapheresis, infliximab 5 mg/kg, three doses	Survived
Yamaguchi et al. (2018)	60, M	Melanoma	Nivo 2 mg/kg	13	ECMO, IABP, intravenous prednisolone 1000 mg/day for 3 days + IVIG at 50 g/day for 2 days	Survived
Imai et al. (2018)	70, M	Squamous cell carcinoma of lung	Pembro (200 mg)	2	Intravenous methylprednisolone (1 g/day) for 3 days, IVIG 1 g/kg for 2 days, ECMO, IABP	Died

ECMO extracorporeal membrane oxygenation, ICI immune checkpoint inhibitors, IABP intraaortic balloon pump, IVIG intravenous immunoglobulin, ipi ipilimumab, nivo nivolumab, pembro pembrolizumab, mg/kg milligrams/kilogram body weight, NA not available